Recent Updates
Recently added Catalysts
CGTX Positive Sentiment

Episode 9: Executing Clinical Research in Dementia with Lewy Bodies (DLB)

Tuesday, October 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Episode 9 of the series features a discussion on executing clinical research in Dementia with Lewy Bodies (DLB). Moderated by Anthony Caggiano, the episode includes insights from experts such as Dr. James E. Galvin and Dr. Lawrence S. Honig. Key topics include comparisons between Alzheimer's disease and DLB, as well as the SHIMMER study design and metrics for success.
Price reaction · baseline $0.4717 (2024-10-21 close) · hit pre-market · clean, no other CGTX news in the window
day 0 close · peak
+2.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Expert insights from leading professionals in dementia research.
  • Focus on innovative clinical research methodologies.
  • Discussion on the SHIMMER study design and outcomes.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
8.3%
average across 6 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Lead asset
Oxytocin
Phase 2 · Oxidative Stress

Full Press Release Details

Episode 9: Executing Clinical Research in Dementia with Lewy Bodies (DLB)
Featuring:
Anthony Caggiano, M.D., Ph.D.
(moderator)
Cognition Therapeutics
Chief Medical Officer
James E. Galvin, MD, MPH.
University of Miami
Director of the Comprehensive Center for Brain Health, Miller School of Medicine
Lawrence S. Honig, MD, PhD, FAAN
Columbia University
Professor of Neurology, Irving Medical Center
David Shprecher, D.O.
Banner Sun Health Research Institute
Movement Disorder Director, Banner Sun Health
Clinical Associate Professor, University of Arizona
Index:
0:00
Introduction
0:45
Comparing Alzheimer’s disease and DLB
5:02
SHIMMER Design and Outcomes
10:22
Metrics for Success in a Signal-finding Study
share this video

Frequently Asked Questions

What is the focus of Episode 9?

Episode 9 focuses on executing clinical research in Dementia with Lewy Bodies.

Who are the featured experts in this episode?

Featured experts include Dr. Anthony Caggiano, Dr. James E. Galvin, and Dr. Lawrence S. Honig.

What does the SHIMMER study involve?

The SHIMMER study design and outcomes are discussed as part of the episode.

How does DLB compare to Alzheimer's disease?

The episode includes a comparison between Dementia with Lewy Bodies and Alzheimer's disease.

ShareAdd on Google
Tags: CGTX Viatris Investor Conferences Healthcare Dementia Lewy Bodies Clinical Research Cognition Therapeutics SHIMMER Study
Last updated: Oct 22, 2024

Biotech snapshot

Cash runway
$34M liquidity · $1M/mo burn
~33 mo
Minimal dilution risk
Lead asset
OxytocinPhase 2
Oxidative Stress →

Catalyst track record

+35%
best trade around CGTX's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CGTX.

See every catalyst's timing & PoA →